Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
In patients with type 2 diabetes, the medication's glucose-lowering effects may diminish as plasma concentrations fall below therapeutic thresholds
For women managing menopause-related weight gain, long-term budgeting matters more than the first-month price
You may also be eligible for a Wegovy coupon or savings card
Compounded Tirzepatide Through PlexusDx PlexusDx partners with licensed 503A compounding pharmacies to prepare custom tirzepatide injections tailored to your dosing schedule and preferences
:max_bytes(150000):strip_icc()/GettyImages-1807240274-2c7c39cb23f34a97bb2d8620911c343d.jpg)
US$ 27.95
US$ 20.71
US$ 26.07
US$ 29.36
US$ 25.25
